Friday, October 23, 2026

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity through early 2028.

EROC $453M

Monte Independent Investment Research 25h ago 4 clicks

47h ago UNCY $108M

Unicycive (UNCY):

Triple S Special Situations Investing 4 clicks

Oct 21 BMBL $783M

Bumble is being taken private

Modern Value Investing 8 clicks

From X

@marginofdanger Oct 21 3 clicks

marginofdanger on X

Some drama at the $BWEL annual meeting. They refused to take any questions! Wonder if something is coming.

@catechwilliams Oct 21 1 click

catechwilliams on X

$AMRO. Recent IPO of a deteriorating Australian (now dual-listed) commodity alloys company sourcing out of China. Negative gross margins, hemorrhaging cash, leverage issues compounded by growing capital needs, heading to likely insolvency. Multiple red flags. No valuation support

@TimyanBankAlert Oct 21 4 clicks

Timyan Bank Alert on X

$PLQC - https://t.co/IZooNfjEtT

@StableBread Oct 21 4 clicks

Fajasy on X

“We are in active discussions with some of the largest GPU consumers in the world, with requirements ranging from 10,000-50,000 GPUs. Those discussions are not yet contracts, and we will announce them only when they are.” That’s what Boost Run $BRUN CEO Andrew Karos said on the Q2 call. None of my bear, base, or bull cases considers a contract with one of those buyers. At Thinking Machines’ $3.59/GPU-hour, a single 10,000-GPU contract would bring in $314.5M/year, 78.6% of the $400M 2026 target. Karos also said $BRUN is procuring another $4-5B of computing hardware from multiple manufacturers. If all of it were rented out on three-year contracts at 1.4x TCV-to-capex (contract value divided by what the GPUs cost), the hardware would bring in $1.9-2.3B/year, 4.7-5.8x the 2026 target. But if lessors fund 79.5% of the purchases, as they did in H1 2026, $BRUN would also take on $3.2-4.0B of new lease debt. So how $BRUN finances the procurement decides how much of the $1.9-2.3B reaches shareholders.

@stockgutter Oct 21 5 clicks

SG on X

there is no investor platform moving faster these days than @finviz_com. It has replaced @KoyfinCharts as my starting point for looking at US-listed stocks, though I continue to be a paid subscriber of both. Recently it rolled out a dilution analysis for stocks with a <$500M market cap. Well done! Here is an example of the data for $OGI just because that is the stock I was looking at when I noticed the feature.

@Mr_Neutral_Man Oct 21 3 clicks

Mr Neutral Man aka "Howard Marks of REITs” on X

@Jefffeldman I own calls in $USO As a human, I would hate to make a windfall from it if oil goes to $150-200/bbl But it's my job to protect my investors

@BlueDuckCap Oct 21 2 clicks

BDC on X

This is a big deal. Strategic acquisition and verticalization of value based oncology care continues leaving $STLN as uniquely scare and thus strategic from here. AONC has no speciality pharma piece and yet is getting bought for 17x gross profit. $STLN is the last multi state actually-acquirable platform. What's left outside STLN is subscale: Utah Cancer Specialists (~40), Cancer Care Northwest (~30), Western Michigan (~30), plus Levitate Ridge's early West Coast platform. There are 2,000+ oncology groups in the US, but almost none with multi-state density. Cardinal has the smallest footprint and no VBC capability, which makes it the most plausible remaining strategic — followed by a payer (Carelon, Optum) or PE. Key point is that we believe $STLN is the much better asset and putting the 17x gross profit acquisition multiple on runrate 2027 estimates gets us ~$25 stock. Not advice.

@Mr_Neutral_Man Oct 21 1 click

Mr Neutral Man aka "Howard Marks of REITs” on X

We now know that Pine Tree bought out $SITC 20% JV stake and issued a $644MM valuation in its press release Seems like everyone got what they wanted 80% JV partner stay in the deal Site Center got $32MM Pine Tree allegedly bought at 17% asset disc and 40% equity disc https://t.co/XeRiXZo1eA

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $291M

Guardian Research Oct 21 4 clicks

Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet

Sagimet Biosciences' denifanstat enters a fully funded U.S. acne registration trial after Phase 3 results, with SGMT trading below cash and…

SGMT $676M

Equity Eagle Oct 21 3 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M

Calvin Blissett Oct 20 10 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $492M

Trade Ideas Flow Oct 19 21 clicks

Sell Eagle Point Credit Now - Match The Loss With Portfolio Gains To Lower Income Taxes

Eagle Point Credit's NAV is down 25% YTD and shares nearly 50%, while its expense ratio climbed to 9.21% despite a 25% yield.

ECC $367M

Anthony Cataldo Oct 19 5 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $292M

TSOH Investment Research Oct 19 18 clicks

LendingTree (NASDAQ: $TREE) – A Cyclical Comeback Story Priced as if the Cycle Never Turns

LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…

TREE $373M

Substack von Philipp Oct 19 10 clicks

First Financial: Acquisitions Drive 2027 Growth

First Financial’s merger with First Illinois Financial is expected to lift net interest income and ROE from 2027 after Q2 net income rose…

THFF $887M

Sorrento Research Oct 18 2 clicks

GLOO: Gloo's own filings make the short case

Gloo's $3.25 follow-on, going-concern warning and $28.0 million first-half cash burn frame the short case against its acquisition-driven…

GLOO $291M

Guardian Research Oct 16 18 clicks

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M

Orphan REITs Oct 16 5 clicks

PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $103M

Value Investors Club Jul 25

Gladstone Investment: High Dividend Increases And NAV Gains, But Very Risky

Gladstone Investment's 50% equity portfolio drove NAV and dividend gains, but five holdings make up 44.5% of fair value and heighten Level…

GAIN $584M

Stephen Nemo Oct 21 4 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $783M

TSOH Investment Research Oct 16 12 clicks

Problems at Dream Finders Homes (DFH)

Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…

DFH $839M

Hunterbrook Oct 15 15 clicks

Park Aerospace: The Q2'27 Sell-Off Misreads a Sole-Source Defense Supplier

Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…

PKE $558M

Monte Independent Investment Research Oct 15 14 clicks

flyExclusive: Sell Despite Strong Turnaround

FlyExclusive posted 22% Q2 revenue growth and a 20.4% gross margin, but negative free cash flow, net debt and preferred capital leave…

FLYX $59M

Dhierin Bechai Oct 15 1 click

Private Equity Prints Multibaggers With This Pattern. No One is Talking About It.

Shenandoah Telecommunications’ Glo Fiber buildout ends this year, and private infrastructure investors’ repeated fiber deals frame a…

SHEN $552M

Phynvesting Oct 14 22 clicks

SED Energy: The 40% Dividend. Signal or Noise?

SED Energy's proposed Ventura merger projects a 22% to 40% dividend yield, but idle tender barges, debt and repayments materially reduce…

SBDXF $509M

Cannibal Stocks Oct 13 8 clicks

Cabaletta Bio: 40% Sell-Off Creates An Opportunity Despite Cash Concerns

Cabaletta Bio's 40% sell-off leaves CABA below its $2.41 pipeline value ahead of pivotal rese-cel autoimmune data in 2027, despite dilution…

CABA $263M

Cypriot Invests Oct 13 2 clicks

Monte Investments Market Brief Vol. CXXXI

Park Aerospace reported 27% revenue growth and 72% EPS growth, supported by composite materials for Airbus engines and PAC-3 rocket motors.

PKE $558M

Monte Independent Investment Research Oct 13 5 clicks

Friday, October 23, 2026

marginofdanger on X

catechwilliams on X

Timyan Bank Alert on X

Fajasy on X

SG on X

Mr Neutral Man aka "Howard Marks of REITs” on X

BDC on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 55 of 247

X accounts we follow

Investor letters we follow

Sectors